1
|
Béduer A, Bonini F, Verheyen CA, Genta M, Martins M, Brefie-Guth J, Tratwal J, Filippova A, Burch P, Naveiras O, Braschler T. An Injectable Meta-Biomaterial: From Design and Simulation to In Vivo Shaping and Tissue Induction. Adv Mater 2021; 33:e2102350. [PMID: 34449109 DOI: 10.1002/adma.202102350] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/26/2021] [Revised: 06/14/2021] [Indexed: 06/13/2023]
Abstract
A novel type of injectable biomaterial with an elastic softening transition is described. The material enables in vivo shaping, followed by induction of 3D stable vascularized tissue. The synthesis of the injectable meta-biomaterial is instructed by extensive numerical simulation as a suspension of irregularly fragmented, highly porous sponge-like microgels. The irregular particle shape dramatically enhances yield strain for in vivo stability against deformation. Porosity of the particles, along with friction between internal surfaces, provides the elastic softening transition. This emergent metamaterial property enables the material to reversibly change stiffness during deformation, allowing native tissue properties to be matched over a wide range of deformation amplitudes. After subcutaneous injection in mice, predetermined shapes can be sculpted manually. The 3D shape is maintained during excellent host tissue integration, with induction of vascular connective tissue that persists to the end of one-year follow-up. The geometrical design is compatible with many hydrogel materials, including cell-adhesion motives for cell transplantation. The injectable meta-biomaterial therefore provides new perspectives in soft tissue engineering and regenerative medicine.
Collapse
Affiliation(s)
- Amélie Béduer
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland
- School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland
| | - Fabien Bonini
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland
| | - Connor A Verheyen
- School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland
| | - Martina Genta
- School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland
| | - Mariana Martins
- Volumina-Medical SA, Route de la Corniche 5, Epalinges, CH-1066, Switzerland
| | - Joé Brefie-Guth
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland
| | - Josefine Tratwal
- Department of Biomedical Sciences, Laboratory of Regenerative Hematopoiesis, University of Lausanne, Rue du Bugnon 27, Lausanne, CH-1011, Switzerland
| | - Aleksandra Filippova
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland
| | - Patrick Burch
- School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland
- Volumina-Medical SA, Route de la Corniche 5, Epalinges, CH-1066, Switzerland
| | - Olaia Naveiras
- Department of Biomedical Sciences, Laboratory of Regenerative Hematopoiesis, University of Lausanne, Rue du Bugnon 27, Lausanne, CH-1011, Switzerland
- CHUV, Hematology Service, Department of Oncology, Rue du Bugnon 46, Lausanne, CH-1011, Switzerland
| | - Thomas Braschler
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland
| |
Collapse
|